miércoles, 21 de octubre de 2026

FDA Issues Final Guidance on Prescription Drug Apps and Software New policy clarifies when app content requires FDA review and how drug-connected software must be described on medication labels

https://www.fda.gov/news-events/press-announcements/fda-issues-final-guidance-prescription-drug-apps-and-software

No hay comentarios: